Rhodium-catalyzed cycloaddition of carbonyl ylides for the synthesis of spiro[furo[2,3-a]xanthene-2,3′-indolin]-2′-one scaffolds

B. V. Subba Reddy *a, E. Pravardhan Reddy bd, B. Sridhar c and Y. Jayaprakash Rao *bd
aCentre for Semiochemicals, CSIR-Indian Institute of Chemical Technology, Hyderabad, 500 007, India. E-mail: basireddy@iict.res.in
bDepartment of Chemistry, Osmania University, Hyderabad-500 007, India
cLaboratory of X-ray Crystallography, CSIR-Indian Institute of Chemical Technology, Hyderabad, 500 007, India
dDepartment of Chemistry, Telangana University, Nizamabad-500 007, India

Received 3rd March 2016 , Accepted 10th May 2016

First published on 12th May 2016


Abstract

An intramolecular cycloaddition of oxonium ylides generated from 3-diazooxindole and a bifunctional substrate i.e. 2-methyl-2-(4-methylpent-3-en-1-yl)-2H-chromene-3-carbaldehyde has been achieved using 5 mol% of Rh2(OAc)4 to produce highly substituted 3,3,5a-trimethyl-3a,5,5a,11b-tetrahydro-3H,4H-spiro[furo[2,3-a]xanthene-2,3′-indolin]-2′-ones in good yields with high diastereoselectivity. This is the first example of the synthesis of biologically relavant polycyclic frameworks from readily accessible precursors.


Introduction

Spirooxindoles are often found in several natural products and medicinally important molecules.1 In particular, the 4,5-dihydro-3H-spiro[furan-2,3′-indolin]-2′-one core is an integral part of many natural products and biologically active molecules (Fig. 1).2 Among them, N-methylwelwitindolinone D isonitrile inhibits the growth of lung adenocarcinoma (A549) cells and hepatocellular carcinoma (HepG2) cells.3 Gelsedine-type indole alkaloids are known to exhibit strong cytotoxic effects against A431 human epidermoid carcinoma cells.4 Therefore, the development of efficient methods for the synthesis of novel spiro-oxindoles and evaluation of their bioactivities are of great importance in drug discovery.5 On the other hand, α-diazo carbonyl compounds are versatile intermediates and susceptible to undergo various transformations such as cyclopropanation, C–H or heteroatom-H insertion, cycloaddition and ylide formation.6,7
image file: c6ra05661j-f1.tif
Fig. 1 Examples of spirofurooxindole frameworks.

In particular, the cycloaddition of carbonyl ylides with dipolarophiles provides a synthetically powerful way to make a variety of 5-membered oxacycles.8 Furthermore, an intramolecular generation of carbonyl ylides and their subsequent cycloadditions are important for the construction of bridged oxacycles.9

However, the development of an operationally simple and efficient strategy in generating a novel series of polycyclic spirooxindoles is highly desirable. Because it provides a rapid access to highly substituted polycyclic compounds with high structural diversity and complexity in a single step process.

Following our research interest on α-diazocarbonyl compounds,10 we herein report a novel and efficient approach for the synthesis of biologically active polycyclic spiro compounds through a Rh-catalyzed cycloaddition of carbonyl ylides generated from diazoamide and chromene-3-carboxaldehyde (Scheme 1).


image file: c6ra05661j-s1.tif
Scheme 1 Cycloaddition of 3-diazooxindole with chromene-3-carbaldehyde.

In this reaction, oxonium ylides undergo an intramolecular cycloaddition with a tethered olefin to generate the spiro cyclic frameworks. The intramolecular version is completely regio- and stereoselective affording the products in good yields. The reaction is highly chemoselective as there is no cyclopropanation between α-diazoketone and olefin. The method is operationally simple, exquisitely selective, and works with diverse substrates. As a model reaction, we investigated the cycloaddition of carbonyl ylide generated from 1 equiv. of N-methyl 3-diazoxindole (1) and 1.1 equiv. of alkene tethered chromene-3-carboxaldehyde (2) using 5 mol% Rh2(OAc)4 in dry dichloroethane. The reaction proceeded smoothly at room temperature affording the expected spirofurooxindole 3a in 80% yield as a single diastereomer. The structure of 3a was confirmed by NMR, IR and HRMS analysis. To optimize the reaction conditions, we screened the reaction with different amounts of the catalyst. After several experiments, we found that 5 mol% of Rh2(OAc)4 is optimum (entry b, Table 1). No further improvement in conversion was observed either by increasing the amount of catalyst to 10 mol% or by decreasing it to 3 mol% (entries e and f, Table 1). In addition, no further increase in yields were observed even by changing the ratio of substrate 1 and 2 to 1.5[thin space (1/6-em)]:[thin space (1/6-em)]1.0 (entry g, Table 1). The best conversion was achieved using 5 mol% of the catalyst. Next we examined the effect of solvents such as dichloroethane, dichloromethane, benzene and toluene at various temperatures. Among them, dicholoroethane appeared to give the best results in terms of yield and reaction time at room temperature (entries b, e and f, Table 1). Furthermore, the reactions were sluggish in other solvents like THF, dimethoxyethane and acetonitrile affording the desired product in poor yields.

Table 1 Optimization of reaction conditions for 3a
Entry Substrate (1) (equiv.) Substrate (2) (equiv.) Catalysta (mol%) Solvent Time (min) Yield of 3ab (%)
a Reaction was performed in 1 mmol scale. b Yield refers to pure products after chromatography.
a 1.0 1.1 5 DCM 30 73
b 1.0 1.1 5 DCE 30 80
c 1.5 1.0 5 Benzene 50 65
d 1.5 1.0 5 Toluene 60 68
e 1.0 1.1 10 DCE 20 75
f 1.0 1.1 3 DCE 50 70
g 1.5 1.0 5 DCE 30 79


These initial findings encouraged us to study its scope with other substrates. The reaction was performed with different 3-diazooxindoles possessing substituents on aromatic ring and N-protecting groups. The halo substituents such as chloro- and bromo- at 5-position of 3-diazooxindole gave the desired products in good yields (entries d–f j–l, Table 2). The presence of protective group on nitrogen showed some effect on conversion. The 3-diazooxindole bearing electron-releasing N-protective groups such as N-methyl, N-benzyl, and N-propargyl furnished the products in high yields (entries a–m, Table 2). Conversely, N-Boc protected 3-diazooxindoles gave the products in lower yields than N-methyl-, N-benzyl- and N-propargyl derivatives (entries n–p, Table 2). However, 1-methyl-5-methoxy-3-diazooxindole gave the desired product in 75% yield under similar conditions (entry q, Table 2). The scope of this method was further extended to substituted chromene-3-carboxaldehydes such as 5-chloro-, and 5-bromo- derivatives (entries b, c, e, f, h, i, k, l, Table 2). No significant electronic effect of the substituents on substrate 2 was observed.

Table 2 [3 + 2] cycloadditon of carbonyl ylidesa

image file: c6ra05661j-u1.tif

Entry R1/R2 R3 Product (3)a Yieldb (%)
a All the reactions were performed using Rh2(OAc)4 (5 mol%), diazoamide (1 equiv.), chromene-3-carboxaldehyde (1.1 equiv.) in dry DCE at 25 °C over 30 min. b Yield refers to pure product after column chromatography.
a CH3/H H 3a 81
b CH3/H Cl 3b 80
c CH3/H Br 3c 78
d CH3/Cl H 3d 83
e CH3/Cl Cl 3e 79
f CH3/Cl Br 3f 81
g Bn/H H 3g 85
h Bn/H Cl 3h 84
i Bn/H Br 3i 84
j Bn/Br H 3j 85
k Bn/Br Cl 3k 82
l Bn/Br Br 3l 83
m Propargyl/H H 3m 88
n Boc/H H 3n 70
o Boc/H Cl 3o 60
p Boc/H Br 3p 65
q CH3/CH3O H 3q 75


Finally, the structure of 3j was confirmed unambiguously by a single crystal X-ray analysis as shown in Fig. 2 (Table 2, entry j).11


image file: c6ra05661j-f2.tif
Fig. 2 ORTEP diagram of 3j.

Mechanistically, the reaction was assumed to be proceeded through a [3 + 2] cycloaddition between 1 and 2. The rhodium carbenoid 4, formed in situ from 3-diazooxindole (1) and Rh2(OAc)4 and reacts with chromene-3-carboxaldehyde (2) to generate the carbonyl ylide 5. A subsequent cycloaddition of carbonyl ylide (5) with an internal olefin would give the desired product 3 (Scheme 2).


image file: c6ra05661j-s2.tif
Scheme 2 A plausible mechanism.

Finally, we were interested to examine the reactivity of the analogue of 2 (2x) with N-methyl 3-diazoxindole (1) using 5 mol% of Rh2(OAc)4 in DCE at room temperature. To our surprise, no desired product was obtained under similar conditions (Scheme 3).


image file: c6ra05661j-s3.tif
Scheme 3 Cycloaddition between 3-diazooxindole (1) and 2x.

Conclusion

In conclusion, we have developed an efficient strategy for the stereoselective synthesis of polycyclic frameworks through a 1,3-dipolar cycloaddition. This method is operationally simple and works under mild conditions. Due to a broad range of biological activity of spirooxindole derivatives, this method will find a significant application in medicinal chemistry.

Acknowledgements

EPR thanks UGC, New Delhi, for the award of a fellowship. BVS thanks BRNS, Mumbai, for the financial support under BSC grant number 37(2)/14/24/2015 for this research.

References and notes

  1. (a) M. J. James, P. O'Brien, R. J. K. Taylor and W. P. Unsworth, Chem.–Eur. J, 2015, 21, 1–27 CrossRef; (b) G. S. Singh and Z. Y. Desta, Chem. Rev., 2012, 112, 6104 CrossRef CAS PubMed.
  2. (a) Y. Zheng, C. M. Tice and S. B. Singh, Bioorg. Med. Chem. Lett., 2014, 24, 3673 CrossRef CAS PubMed; (b) E. D. Styduhar, A. D. Huters, N. A. Weires and N. K. Garg, Angew. Chem., Int. Ed., 2013, 52, 12422 CrossRef CAS PubMed; (c) B. M. Trost and M. K. Brennan, Synthesis, 2009, 3003 CrossRef CAS.
  3. A. K. Franz, P. D. Dreyfuss and S. L. Schreiber, J. Am. Chem. Soc., 2007, 129, 1020 CrossRef CAS PubMed.
  4. M. Kitajima, T. Nakamura, N. Kogure, M. Ogawa, Y. Mitsuno, K. Ono, S. Yano, N. Aimi and H. Takayama, J. Nat. Prod., 2006, 69, 715 CrossRef CAS PubMed.
  5. (a) B. Yin, L. Huang, X. Wang, J. Liu and H. Jiang, Adv. Synth. Catal., 2013, 355, 370 CrossRef CAS; (b) B.-L. Yin, J.-Q. Lai, Z.-R. Zhang and H.-F. Jiang, Adv. Synth. Catal., 2011, 353, 1961 CrossRef CAS.
  6. (a) Z.-Y. Cao, X. Wang, C. Tan, X.-L. Zhao, J. Zhou and K. Ding, J. Am. Chem. Soc., 2013, 135, 8197 CrossRef CAS PubMed; (b) B. Alcaide, P. Almendros, C. Aragoncillo, R. Callejo, M. P. Ruiz and M. R. Torres, Eur. J. Org. Chem., 2012, 2359 CrossRef CAS; (c) M. Li, L. Zan, D. Prajapati and W.-H. Hu, Org. Biomol. Chem., 2012, 10, 8808 RSC; (d) Z.-Y. Cao, F. Zhou, Y.-H. Yu and J. Zhou, Org. Lett., 2012, 15, 42 CrossRef PubMed.
  7. (a) S.-F. Zhu, Y. Cai, H.-X. Mao, J.-H. Xie and Q.-L. Zhou, Nat. Chem., 2010, 2, 546 CrossRef CAS PubMed; (b) S.-F. Zhu, X. Xu, J. A. Perman and X. P. Zhang, J. Am. Chem. Soc., 2010, 132, 12796 CrossRef CAS PubMed; (c) Y.-J. Lian and H. M. L. Davies, J. Am. Chem. Soc., 2010, 132, 440 CrossRef CAS PubMed; (d) C. Marti and E. M. Carreira, J. Am. Chem. Soc., 2005, 127, 11505 CrossRef CAS PubMed; (e) M. P. Doyle, M. A. McKervey and T. Ye, Chem. Commun., 1997, 983 RSC; (f) T. Ye and M. A. McKervey, Chem. Rev., 1994, 94, 1091 CrossRef CAS; (g) A. Padwa and D. J. Austin, Angew. Chem., Int. Ed., 1994, 33, 1797 CrossRef; (h) D. J. Miller and C. J. Moody, Tetrahedron, 1995, 51, 10811 CrossRef CAS; (i) A. Padwa and S. A. Hornbuckle, Chem. Rev., 1991, 91, 263 CrossRef CAS.
  8. (a) A. Ford, H. Miel, A. Ring, C. N. Slattery, A. R. Maguire and M. A. McKervey, Chem. Rev., 2015, 115, 9981 CrossRef CAS PubMed and references cited therein; (b) D. M. Hodgson, A. H. Labande and F. Y. T. M. Pierard, Synlett, 2003, 59 CAS; (c) D. M. Hodgson, F. Y. T. M. Pierard and P. A. Stupple, Chem. Soc. Rev., 2001, 30, 50 RSC; (d) A. Padwa and M. D. Weingarten, Chem. Rev., 1996, 96, 223 CrossRef CAS PubMed; (e) D. M. Hodgson, P. A. Stupple, F. Y. T. M. Pierard, A. H. Labande and C. Johnstone, Chem.–Eur. J., 2001, 7, 4465 CrossRef CAS PubMed.
  9. (a) C. H. Kim, K. P. Jang, S. Y. Choi, Y. K. Chung and E. Lee, Angew. Chem., Int. Ed., 2008, 47, 4009 CrossRef CAS PubMed; (b) D. M. Hodgson, P. A. Stupple and C. Johnstone, Tetrahedron Lett., 1997, 38, 6471 CrossRef CAS; (c) J. E. Baldwin, A. V. W. Mayweg, K. Neumann and G. J. Pritchard, Org. Lett., 1999, 1, 1933 CrossRef CAS PubMed; (d) A. Padwa, E. A. Curtis and V. P. Sandanayaka, J. Org. Chem., 1996, 61, 73 CrossRef CAS; (e) A. Padwa, D. J. Austin, A. T. Price and M. D. Weingarten, Tetrahedron, 1996, 52, 3247 CrossRef CAS.
  10. (a) B. V. S. Reddy, M. R. Reddy, Y. G. Rao, J. S. Yadav and B. Sridhar, Org. Lett., 2013, 15, 464 CrossRef CAS PubMed; (b) T. Rajasekaran, G. Karthik, B. Sridhar and B. V. S. Reddy, Org. Lett., 2013, 15, 1512 CrossRef CAS PubMed; (c) B. V. S. Reddy, T. Rajasekaran, G. Karthik and T. P. Rao, Tetrahedron Lett., 2012, 53, 3416 CrossRef.
  11. CCDC 893601 contains supplementary crystallographic data of 3j.

Footnote

Electronic supplementary information (ESI) available: Copies of 1H and 13C NMR spectra of products. CCDC 893601. For ESI and crystallographic data in CIF or other electronic format see DOI: 10.1039/c6ra05661j

This journal is © The Royal Society of Chemistry 2016